BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Genesis Research and Development Corporation (GEN.NZ) Suspends New Zealand Operations Due to Lack of Funding


5/3/2010 8:13:22 AM

Auckland, New Zealand, 3 May 2010 - Genesis Research and Development Corporation Ltd advises that it is suspending operations in New Zealand due to lack of funding, but is negotiating several transactions that are intended to maintain value for shareholders.

Solirna Biosciences Ltd Solirna's scientific and management team has made substantial progress with development of its single stranded gene silencing technology. Further funding of Solirna is being discussed, with future development of the technology likely to be undertaken overseas.

Pure Power Global Negotiations with Pure Power Global for the settlement of the outstanding debt relating to the sale of BioJoule Ltd have been continuing for a long period. In recognition of the significant change in asset values and the difficulty in arranging funding since the global financial crisis, Genesis has agreed to accept a significantly reduced amount if payment is made promptly. An initial deposit is being paid and complete settlement is intended to occur in May.

Corporate Activity

Genesis is currently discussing a proposed transaction to acquire a company with several therapeutic development projects, including one that is close to entering clinical development. The vendors have indicated that funds are available to allow Genesis to make a placement of shares which would raise approximately $450,000, with further more significant funding likely to follow.

Existing Genesis assets, including its royalty rights, and equity interests in Solirna Biosciences Ltd and Real Time Genomics, may be transferred to a separate entity. Existing Genesis shareholders would then receive shares in that new entity and would continue to hold their existing shares in Genesis. These transactions have not yet been fully developed or agreed with the other parties involved, and will be subject to approval of shareholders. Genesis Chief Executive, Stephen Hall, said, "It is now apparent that sufficient funding is not available to allow ongoing development of the Solirna technology in New Zealand. The Foundation for Research Science and Technology has declined to provide any substantive funding and at this stage the Japanese investor in Solirna is still determining whether it will provide further funding.

"Further information will be provided to shareholders as the plans discussed above are developed further."

Stephen G. Hall - Chief Executive Genesis Research & Development Corporation Limited http://www.genesis.co.nz PO Box 50 Shortland St, Auckland 1140, New Zealand One Fox Street, Parnell, Auckland 1052, New Zealand NZSX:GEN ASX:GEN

Tel +64 9 373 5600 Direct:+64 9 374 3710 Mobile +64 21 715 725 Fax +64 9 373 5601 e-mail s.hall@genesis.co.nz



Read at BioSpace.com
Read at News Release
Read at Scoop
Read at News Release
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES